AI MARKET SCANNING

Grace Therapeutics Inc

📅 Next Catalyst: Nov 16, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -1.65%
MAX GAP RECORD -3.60%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $GRCE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 16, 2026 Earnings Release 2026-11-16 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
+0.00%
Jun 18, 2026 Earnings Release 2026-06-18 (BEFORE OPEN)
+0.00%
Feb 12, 2026 Earnings Release 2026-02-12 (BEFORE OPEN)
+1.67%
Nov 13, 2025 Earnings Release 2025-11-13 (BEFORE OPEN)
-0.33%
Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN)
-0.32%
Jun 23, 2025 Earnings Release 2025-06-23 (BEFORE OPEN)
+0.00%
Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN)
-2.59%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.0%
Bullish Gaps (1)
Bearish Gaps (6)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $GRCE

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Grace Therapeutics, Inc. engages in the development and commercialization of drug candidates for rare and orphan diseases. It focuses on utilizing proprietary technologies to improve the performance of currently marketed drugs. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton,…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗